In early-stage trials called dose escalation studies, drug developers usually want to test progressively higher doses of their therapies.
Not Perspective Therapeutics. The radiopharma biotech …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
A computer algorithm can efficiently find genetic mutations that work together to drive cancer as well as other important genetic clues that researchers might someday
Amylyx Pharmaceuticals announced Thursday that it’s removing its amyotrophic lateral sclerosis (ALS) drug sodium phenylbutyrate and taurursodiol (Relyvrio), also known as AMX0035, from U.S. and
Share this article “Cardiovascular disease is preventable in many cases and early identification of risk is essential, especially for people at high risk,“ emphasizes the American